comparemela.com

Latest Breaking News On - Glenn goddard - Page 1 : comparemela.com

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United-states
Yanan-zhu
Debjit-chattopadhyay
Kostas-biliouris
Laura-sepp-lorenzino
Ian-karp
Glenn-goddard
John-leonard
David-lebwohl
Brian-cheng
Troy-langford
Maury-raycroft

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript February 22, 2024 Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome […]

Laura-sepp-lorenzino
Maury-raycroft
Glenn-goddard
New-england-journal
Intellia-in-vivo
Chief-scientific-officer
Recode-therapeutics
Allo-solution
Chief-financial-officer
Wind-power
Solar-stocks-to-buy

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript

Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc.

United-states
America
Ian-karp
Laura-sepp-lorenzino
Glenn-goddard
Greg-harrison
David-lebwohl
Gena-wang
Maury-raycroft
John-leonard
Nasdaq
Intellia-therapeutics-inc

Aigen Investment Management LP Takes Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Aigen Investment Management LP purchased a new stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 17,569 shares of the company’s stock, valued at approximately $556,000. Other institutional investors have also made changes to […]

Canada
Glenn-goddard
Johnm-leonard
Dekabank-deutsche-girozentrale
Securities-exchange-commission
Intellia-therapeutics-inc
Envestnet-asset-management-inc
Rafferty-asset-management
Royal-bank
Nasdaq
Fund-management-co
Morgan-stanley

Wedbush Reiterates "Neutral" Rating for Intellia Therapeutics (NASDAQ:NTLA)

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report)‘s stock had its “neutral” rating reaffirmed by equities research analysts at Wedbush in a research note issued on Thursday, RTT News reports. They presently have a $29.00 price objective on the stock. Wedbush’s price target would indicate a potential upside of 1.86% from the company’s current price. Other […]

Canada
David-lebwohl
Glenn-goddard
Norges-bank
Intellia-therapeutics-inc
Wolfe-research
Investment-management
Nasdaq
Royal-bank
Morgan-stanley
Intellia-therapeutics
Get-free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.